

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chemical homeostasis within a tissue (GO:0048875) | 9.25231444 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.78386198 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 4.55045768 |
| 4 | low-density lipoprotein particle clearance (GO:0034383) | 4.45515427 |
| 5 | pattern specification involved in kidney development (GO:0061004) | 4.04675930 |
| 6 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.04297244 |
| 7 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.94047210 |
| 8 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.91939351 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 3.89081479 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.79926808 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.79926808 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.79926808 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.79926808 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.79926808 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 3.79926808 |
| 16 | regulation of vitamin metabolic process (GO:0030656) | 3.77633132 |
| 17 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.75906600 |
| 18 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.66028765 |
| 19 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.63431729 |
| 20 | response to peptidoglycan (GO:0032494) | 3.62514089 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.56585392 |
| 22 | regulation of cholesterol storage (GO:0010885) | 3.52302501 |
| 23 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.37851948 |
| 24 | regulation of chronic inflammatory response (GO:0002676) | 3.34595453 |
| 25 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.33505373 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.31011219 |
| 27 | lung lobe morphogenesis (GO:0060463) | 3.27019174 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.25783448 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.25783448 |
| 30 | apoptotic cell clearance (GO:0043277) | 3.25707219 |
| 31 | cellular response to nitric oxide (GO:0071732) | 3.23257848 |
| 32 | regulation of macrophage chemotaxis (GO:0010758) | 3.22489323 |
| 33 | positive regulation of heat generation (GO:0031652) | 3.19198856 |
| 34 | macrophage chemotaxis (GO:0048246) | 3.19023867 |
| 35 | myeloid dendritic cell differentiation (GO:0043011) | 3.17859078 |
| 36 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15733612 |
| 37 | cell adhesion mediated by integrin (GO:0033627) | 3.15019962 |
| 38 | response to xenobiotic stimulus (GO:0009410) | 3.12398659 |
| 39 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.11716871 |
| 40 | NIK/NF-kappaB signaling (GO:0038061) | 3.10936901 |
| 41 | response to hyperoxia (GO:0055093) | 3.08153511 |
| 42 | response to increased oxygen levels (GO:0036296) | 3.08153511 |
| 43 | leukocyte mediated cytotoxicity (GO:0001909) | 3.07519352 |
| 44 | cellular response to interferon-alpha (GO:0035457) | 3.07064209 |
| 45 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.04998637 |
| 46 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.04743488 |
| 47 | eosinophil chemotaxis (GO:0048245) | 3.04236638 |
| 48 | positive regulation of macrophage cytokine production (GO:0060907) | 3.04020525 |
| 49 | negative regulation of fatty acid transport (GO:2000192) | 3.02599598 |
| 50 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.01869629 |
| 51 | glycosphingolipid catabolic process (GO:0046479) | 3.01832891 |
| 52 | regulation of fever generation (GO:0031620) | 2.99901663 |
| 53 | oligosaccharide catabolic process (GO:0009313) | 2.98109639 |
| 54 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.97109073 |
| 55 | virion attachment to host cell (GO:0019062) | 2.96676613 |
| 56 | adhesion of symbiont to host cell (GO:0044650) | 2.96676613 |
| 57 | monocyte chemotaxis (GO:0002548) | 2.94467510 |
| 58 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91442719 |
| 59 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.91022601 |
| 60 | defense response to protozoan (GO:0042832) | 2.90801704 |
| 61 | response to protozoan (GO:0001562) | 2.89995467 |
| 62 | regulation of endothelial cell differentiation (GO:0045601) | 2.89543032 |
| 63 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.88427456 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.87916070 |
| 65 | negative regulation of lipid storage (GO:0010888) | 2.87264572 |
| 66 | positive regulation of interferon-alpha production (GO:0032727) | 2.85441216 |
| 67 | peptide catabolic process (GO:0043171) | 2.83965667 |
| 68 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81580805 |
| 69 | regulation of podosome assembly (GO:0071801) | 2.80557662 |
| 70 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.79869317 |
| 71 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.79834938 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.79415651 |
| 73 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.79293445 |
| 74 | cellular response to lipopolysaccharide (GO:0071222) | 2.78147604 |
| 75 | macrophage activation involved in immune response (GO:0002281) | 2.77227244 |
| 76 | dendritic cell differentiation (GO:0097028) | 2.76067348 |
| 77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75685679 |
| 78 | hemidesmosome assembly (GO:0031581) | 2.75059044 |
| 79 | morphogenesis of an endothelium (GO:0003159) | 2.74878951 |
| 80 | endothelial tube morphogenesis (GO:0061154) | 2.74878951 |
| 81 | granulocyte activation (GO:0036230) | 2.74853052 |
| 82 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.74805971 |
| 83 | hyaluronan catabolic process (GO:0030214) | 2.73862904 |
| 84 | reactive oxygen species biosynthetic process (GO:1903409) | 2.73693863 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 2.73438806 |
| 86 | response to interferon-alpha (GO:0035455) | 2.73239769 |
| 87 | positive regulation of p38MAPK cascade (GO:1900745) | 2.72210407 |
| 88 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.71722446 |
| 89 | regulation of type 2 immune response (GO:0002828) | 2.71435615 |
| 90 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.71048249 |
| 91 | keratan sulfate catabolic process (GO:0042340) | 2.70817521 |
| 92 | glycolipid catabolic process (GO:0019377) | 2.70750174 |
| 93 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.69927153 |
| 94 | response to type I interferon (GO:0034340) | 2.69431683 |
| 95 | cellular response to reactive nitrogen species (GO:1902170) | 2.68620464 |
| 96 | cellular response to molecule of bacterial origin (GO:0071219) | 2.68526626 |
| 97 | regulation of interferon-alpha production (GO:0032647) | 2.68131728 |
| 98 | brown fat cell differentiation (GO:0050873) | 2.68062127 |
| 99 | eosinophil migration (GO:0072677) | 2.67600403 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 2.66696419 |
| 101 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.66155517 |
| 102 | germinal center formation (GO:0002467) | 2.66120875 |
| 103 | cellular response to type I interferon (GO:0071357) | 2.65532252 |
| 104 | type I interferon signaling pathway (GO:0060337) | 2.65532252 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 2.64819426 |
| 106 | myeloid dendritic cell activation (GO:0001773) | 2.64262715 |
| 107 | positive regulation of natural killer cell activation (GO:0032816) | 2.62943825 |
| 108 | adhesion of symbiont to host (GO:0044406) | 2.62908046 |
| 109 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.62643462 |
| 110 | neutrophil activation (GO:0042119) | 2.62405103 |
| 111 | lymphocyte chemotaxis (GO:0048247) | 2.62024261 |
| 112 | regulation of immunoglobulin secretion (GO:0051023) | 2.61667114 |
| 113 | response to host immune response (GO:0052572) | 2.61569540 |
| 114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.61569540 |
| 115 | positive regulation of phagocytosis (GO:0050766) | 2.61321438 |
| 116 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.61230081 |
| 117 | positive regulation of type 2 immune response (GO:0002830) | 2.60301829 |
| 118 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.60002942 |
| 119 | sodium-independent organic anion transport (GO:0043252) | 2.59672203 |
| 120 | cellular response to interferon-gamma (GO:0071346) | 2.59398846 |
| 121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59392786 |
| 122 | positive regulation of interleukin-6 production (GO:0032755) | 2.58758875 |
| 123 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.58381269 |
| 124 | response to manganese ion (GO:0010042) | 2.58305575 |
| 125 | decidualization (GO:0046697) | 2.58068429 |
| 126 | pinocytosis (GO:0006907) | 2.55010857 |
| 127 | respiratory burst (GO:0045730) | 2.54786094 |
| 128 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.54491549 |
| 129 | regulation of monocyte chemotaxis (GO:0090025) | 2.54441441 |
| 130 | amino sugar catabolic process (GO:0046348) | 2.53175135 |
| 131 | positive regulation of acute inflammatory response (GO:0002675) | 2.52864989 |
| 132 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52458563 |
| 133 | wound healing, spreading of epidermal cells (GO:0035313) | 2.52340378 |
| 134 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.51894423 |
| 135 | protein localization to endosome (GO:0036010) | 2.51789321 |
| 136 | regulation of macrophage cytokine production (GO:0010935) | 2.51583973 |
| 137 | regulation of phagocytosis (GO:0050764) | 2.51579806 |
| 138 | sphingosine metabolic process (GO:0006670) | 2.51174497 |
| 139 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.51140622 |
| 140 | response to interferon-gamma (GO:0034341) | 2.51029318 |
| 141 | growth hormone receptor signaling pathway (GO:0060396) | 2.50193616 |
| 142 | regulation of T-helper cell differentiation (GO:0045622) | 2.49777243 |
| 143 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.49512873 |
| 144 | substrate-dependent cell migration (GO:0006929) | 2.49358561 |
| 145 | response to nitric oxide (GO:0071731) | 2.48579811 |
| 146 | regulation of mast cell degranulation (GO:0043304) | 2.48465281 |
| 147 | response to interleukin-6 (GO:0070741) | 2.45316220 |
| 148 | regulation of chemokine biosynthetic process (GO:0045073) | 2.45292109 |
| 149 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.43084349 |
| 150 | establishment of endothelial barrier (GO:0061028) | 2.43036376 |
| 151 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.41522066 |
| 152 | glomerular visceral epithelial cell development (GO:0072015) | 2.41346937 |
| 153 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.40041596 |
| 154 | positive regulation of lipid storage (GO:0010884) | 2.39776786 |
| 155 | regulation of mononuclear cell migration (GO:0071675) | 2.39339891 |
| 156 | glomerular epithelial cell development (GO:0072310) | 2.38870181 |
| 157 | regulation of sequestering of triglyceride (GO:0010889) | 2.38752957 |
| 158 | neutrophil mediated immunity (GO:0002446) | 2.38086131 |
| 159 | lipid storage (GO:0019915) | 2.36192579 |
| 160 | T-helper 1 type immune response (GO:0042088) | 2.35542162 |
| 161 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.35107154 |
| 162 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34851391 |
| 163 | response to host defenses (GO:0052200) | 2.34851391 |
| 164 | surfactant homeostasis (GO:0043129) | 11.8257656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.37965790 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.54540324 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.29311389 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.18292241 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.25811596 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.22772777 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.09081454 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90744494 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.78914518 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.78749027 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59301692 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.54087205 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48163052 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41639344 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37466023 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.34468767 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.30161760 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27336202 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24388812 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20644635 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.15631855 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.00713033 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98806539 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.96435372 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.96236216 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91125418 |
| 27 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.82026140 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76337960 |
| 29 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.75837674 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72529473 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70952562 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66404981 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61432284 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61189940 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59020929 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58306270 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56365208 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55361588 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53037763 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49936898 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47357820 |
| 42 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.45985473 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45125334 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44367448 |
| 45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42817539 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41415486 |
| 47 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.40981232 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.40975675 |
| 49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38109175 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37199370 |
| 51 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36885107 |
| 52 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.36800354 |
| 53 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.35088493 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34932297 |
| 55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33793416 |
| 56 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.33556000 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33451078 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32513671 |
| 59 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32017382 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30817317 |
| 61 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30166097 |
| 62 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.29220676 |
| 63 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.28934121 |
| 64 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.28934121 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27988294 |
| 66 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27688216 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25946036 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23660904 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21253920 |
| 70 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20475727 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18350426 |
| 72 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18032761 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16641406 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16262442 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15681940 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15681940 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11668919 |
| 78 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10215642 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10215642 |
| 80 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09718508 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09708277 |
| 82 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08115879 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06061855 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06025085 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05832888 |
| 86 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05444178 |
| 87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04546988 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04147575 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03340227 |
| 90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03309637 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02941450 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01745174 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01617937 |
| 94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01525022 |
| 95 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99898598 |
| 96 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99699343 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99491107 |
| 98 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99142292 |
| 99 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98651059 |
| 100 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97753471 |
| 101 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97295666 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97159149 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95494108 |
| 104 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95219921 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94329527 |
| 106 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92715703 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92652153 |
| 108 | MYB_26560356_Chip-Seq_TH2_Human | 0.92073728 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91723209 |
| 110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91639481 |
| 111 | MAF_26560356_Chip-Seq_TH1_Human | 0.89212788 |
| 112 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88932569 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88542873 |
| 114 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.87919004 |
| 115 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87024977 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86323651 |
| 117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.85583572 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85573115 |
| 119 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85552250 |
| 120 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.85434865 |
| 121 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85267885 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83710468 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83688341 |
| 124 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83176409 |
| 125 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83084659 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82904041 |
| 127 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82588031 |
| 128 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.82473147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 7.29222260 |
| 2 | MP0001958_emphysema | 4.26482161 |
| 3 | MP0003724_increased_susceptibility_to | 4.07194392 |
| 4 | MP0008004_abnormal_stomach_pH | 2.88021842 |
| 5 | MP0005083_abnormal_biliary_tract | 2.75019592 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.62020715 |
| 7 | MP0003436_decreased_susceptibility_to | 2.60943938 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.60560308 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.46596027 |
| 10 | MP0008995_early_reproductive_senescence | 2.40006901 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.39718609 |
| 12 | MP0003303_peritoneal_inflammation | 2.31486131 |
| 13 | MP0002295_abnormal_pulmonary_circulatio | 2.25717657 |
| 14 | MP0001542_abnormal_bone_strength | 2.22651496 |
| 15 | MP0009785_altered_susceptibility_to | 2.20962938 |
| 16 | MP0005388_respiratory_system_phenotype | 2.11219744 |
| 17 | MP0002133_abnormal_respiratory_system | 2.11219744 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 1.99826960 |
| 19 | MP0001177_atelectasis | 1.97727363 |
| 20 | MP0000343_altered_response_to | 1.94250219 |
| 21 | MP0005275_abnormal_skin_tensile | 1.84334100 |
| 22 | MP0002254_reproductive_system_inflammat | 1.83768689 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.80745932 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.78375230 |
| 25 | MP0005671_abnormal_response_to | 1.75988468 |
| 26 | MP0005025_abnormal_response_to | 1.75483234 |
| 27 | MP0002419_abnormal_innate_immunity | 1.75378587 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.67592594 |
| 29 | MP0001790_abnormal_immune_system | 1.66553259 |
| 30 | MP0005387_immune_system_phenotype | 1.66553259 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.66071626 |
| 32 | MP0005164_abnormal_response_to | 1.60829429 |
| 33 | MP0000685_abnormal_immune_system | 1.59579916 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.56880396 |
| 35 | MP0003448_altered_tumor_morphology | 1.53880500 |
| 36 | MP0004272_abnormal_basement_membrane | 1.49328908 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.46777397 |
| 38 | MP0005451_abnormal_body_composition | 1.46720232 |
| 39 | MP0002405_respiratory_system_inflammati | 1.44597353 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.40416375 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.39091811 |
| 42 | MP0003075_altered_response_to | 1.38267382 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.36123658 |
| 44 | MP0006082_CNS_inflammation | 1.35916585 |
| 45 | MP0004130_abnormal_muscle_cell | 1.35399692 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.34967247 |
| 47 | MP0001851_eye_inflammation | 1.33273471 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.31272960 |
| 49 | MP0001879_abnormal_lymphatic_vessel | 1.30345701 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.25441772 |
| 51 | MP0009764_decreased_sensitivity_to | 1.21315658 |
| 52 | MP0005023_abnormal_wound_healing | 1.20207638 |
| 53 | MP0004947_skin_inflammation | 1.19175606 |
| 54 | MP0009840_abnormal_foam_cell | 1.18460338 |
| 55 | MP0002332_abnormal_exercise_endurance | 1.18429125 |
| 56 | MP0004510_myositis | 1.17987035 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.17929276 |
| 58 | MP0003186_abnormal_redox_activity | 1.16912562 |
| 59 | MP0005166_decreased_susceptibility_to | 1.14918118 |
| 60 | MP0005310_abnormal_salivary_gland | 1.14084848 |
| 61 | MP0002452_abnormal_antigen_presenting | 1.11555309 |
| 62 | MP0004883_abnormal_blood_vessel | 1.11499566 |
| 63 | MP0003279_aneurysm | 1.10412128 |
| 64 | MP0005595_abnormal_vascular_smooth | 1.09389120 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.08700435 |
| 66 | MP0003195_calcinosis | 1.07868753 |
| 67 | MP0001175_abnormal_lung_morphology | 1.07469064 |
| 68 | MP0000249_abnormal_blood_vessel | 1.07255151 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.04331503 |
| 70 | MP0003828_pulmonary_edema | 1.03260096 |
| 71 | MP0005165_increased_susceptibility_to | 1.02654575 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.01989153 |
| 73 | MP0000858_altered_metastatic_potential | 1.01888628 |
| 74 | MP0002933_joint_inflammation | 1.00961668 |
| 75 | MP0002723_abnormal_immune_serum | 1.00960392 |
| 76 | MP0005257_abnormal_intraocular_pressure | 0.99789374 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.98207296 |
| 78 | MP0008469_abnormal_protein_level | 0.97670621 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 0.97421676 |
| 80 | MP0003690_abnormal_glial_cell | 0.97388103 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.96416997 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 0.96416997 |
| 83 | MP0003795_abnormal_bone_structure | 0.94863055 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.94829978 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.93946105 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 0.93593663 |
| 87 | MP0004858_abnormal_nervous_system | 0.90866231 |
| 88 | MP0009278_abnormal_bone_marrow | 0.90857479 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.90292540 |
| 90 | MP0001819_abnormal_immune_cell | 0.89099557 |
| 91 | MP0000604_amyloidosis | 0.88234195 |
| 92 | MP0002420_abnormal_adaptive_immunity | 0.86744478 |
| 93 | MP0010329_abnormal_lipoprotein_level | 0.86389371 |
| 94 | MP0003091_abnormal_cell_migration | 0.85961399 |
| 95 | MP0009763_increased_sensitivity_to | 0.85930120 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.85828961 |
| 97 | MP0005670_abnormal_white_adipose | 0.84614758 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.84448917 |
| 99 | MP0000566_synostosis | 0.84113154 |
| 100 | MP0000716_abnormal_immune_system | 0.83826311 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.83545198 |
| 102 | MP0000920_abnormal_myelination | 0.82410976 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.82168306 |
| 104 | MP0001881_abnormal_mammary_gland | 0.82092208 |
| 105 | MP0006054_spinal_hemorrhage | 0.82028335 |
| 106 | MP0001853_heart_inflammation | 0.81748236 |
| 107 | MP0000627_abnormal_mammary_gland | 0.81602871 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.81522735 |
| 109 | MP0002006_tumorigenesis | 0.80921136 |
| 110 | MP0005375_adipose_tissue_phenotype | 0.80668159 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.80507291 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.79830035 |
| 113 | MP0001800_abnormal_humoral_immune | 0.79720008 |
| 114 | MP0003172_abnormal_lysosome_physiology | 0.79477666 |
| 115 | MP0001243_abnormal_dermal_layer | 0.78135507 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.77427534 |
| 117 | MP0005508_abnormal_skeleton_morphology | 0.77331613 |
| 118 | MP0003045_fibrosis | 0.77146881 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.77120076 |
| 120 | MP0002132_abnormal_respiratory_system | 0.76336287 |
| 121 | MP0010386_abnormal_urinary_bladder | 0.74377677 |
| 122 | MP0009115_abnormal_fat_cell | 0.73438189 |
| 123 | MP0003329_amyloid_beta_deposits | 0.69725195 |
| 124 | MP0002060_abnormal_skin_morphology | 0.69609687 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 0.69540095 |
| 126 | MP0005390_skeleton_phenotype | 0.68800365 |
| 127 | MP0001663_abnormal_digestive_system | 0.68557733 |
| 128 | MP0005647_abnormal_sex_gland | 0.64841700 |
| 129 | MP0008874_decreased_physiological_sensi | 0.62992304 |
| 130 | MP0002429_abnormal_blood_cell | 0.61187241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.11825639 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.11825639 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.11825639 |
| 4 | Tubulointerstitial fibrosis (HP:0005576) | 5.23781644 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.04856226 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.57755815 |
| 7 | Tachypnea (HP:0002789) | 4.51222655 |
| 8 | Respiratory distress (HP:0002098) | 4.33796462 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.26102400 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.08443885 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.08443885 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.08443885 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.06992087 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.97100611 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.43377389 |
| 16 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.43369363 |
| 17 | Osteolytic defects of the hand bones (HP:0009699) | 3.43369363 |
| 18 | Hyperactive renin-angiotensin system (HP:0000841) | 3.33227578 |
| 19 | Chronic otitis media (HP:0000389) | 3.28429256 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.26488055 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.26143952 |
| 22 | Disinhibition (HP:0000734) | 3.25396816 |
| 23 | Hematochezia (HP:0002573) | 3.21560965 |
| 24 | Spondylolisthesis (HP:0003302) | 3.10048577 |
| 25 | Renal salt wasting (HP:0000127) | 3.09205932 |
| 26 | Vertebral compression fractures (HP:0002953) | 3.05428284 |
| 27 | Tubulointerstitial abnormality (HP:0001969) | 2.95881370 |
| 28 | Ulnar bowing (HP:0003031) | 2.94213813 |
| 29 | Nuclear cataract (HP:0100018) | 2.93575147 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.92485099 |
| 31 | Loss of speech (HP:0002371) | 2.92482562 |
| 32 | Gout (HP:0001997) | 2.88779594 |
| 33 | Glomerulonephritis (HP:0000099) | 2.86666411 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 2.85784425 |
| 35 | Broad metatarsal (HP:0001783) | 2.85624686 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 2.80767529 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.78574925 |
| 38 | Gingivitis (HP:0000230) | 2.77869203 |
| 39 | Orchitis (HP:0100796) | 2.76817646 |
| 40 | Polycythemia (HP:0001901) | 2.75483478 |
| 41 | Cervical subluxation (HP:0003308) | 2.72642191 |
| 42 | Chronic bronchitis (HP:0004469) | 2.67906872 |
| 43 | Onycholysis (HP:0001806) | 2.66636146 |
| 44 | Cerebral aneurysm (HP:0004944) | 2.66084853 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.64027197 |
| 46 | Aortic aneurysm (HP:0004942) | 2.63537465 |
| 47 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.62389086 |
| 48 | Myositis (HP:0100614) | 2.56545826 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.51616447 |
| 50 | Stomach cancer (HP:0012126) | 2.50925629 |
| 51 | Thick nail (HP:0001805) | 2.50042996 |
| 52 | Pustule (HP:0200039) | 2.47709182 |
| 53 | Thyroid-stimulating hormone excess (HP:0002925) | 2.47560552 |
| 54 | Amyloidosis (HP:0011034) | 2.47177441 |
| 55 | Stomatitis (HP:0010280) | 2.45380744 |
| 56 | Atrophic scars (HP:0001075) | 2.43366804 |
| 57 | Periodontitis (HP:0000704) | 2.43043634 |
| 58 | Vascular tortuosity (HP:0004948) | 2.42780183 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.41830570 |
| 60 | Tubulointerstitial nephritis (HP:0001970) | 2.40178521 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.39566381 |
| 62 | Peritonitis (HP:0002586) | 2.38601034 |
| 63 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37566473 |
| 64 | Mutism (HP:0002300) | 2.36848152 |
| 65 | Purpura (HP:0000979) | 2.35994914 |
| 66 | Ovoid vertebral bodies (HP:0003300) | 2.35989120 |
| 67 | Aortic dissection (HP:0002647) | 2.30926255 |
| 68 | Acanthosis nigricans (HP:0000956) | 2.27479405 |
| 69 | Subacute progressive viral hepatitis (HP:0006572) | 2.24401579 |
| 70 | Axonal loss (HP:0003447) | 2.23036352 |
| 71 | Asymmetric septal hypertrophy (HP:0001670) | 2.22691007 |
| 72 | Increased serum ferritin (HP:0003281) | 2.19695614 |
| 73 | Tetraparesis (HP:0002273) | 2.19515714 |
| 74 | Apathy (HP:0000741) | 2.19268137 |
| 75 | Nephritis (HP:0000123) | 2.18964498 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.18271843 |
| 77 | Hemoptysis (HP:0002105) | 2.17865268 |
| 78 | Tubular atrophy (HP:0000092) | 2.15454634 |
| 79 | Esophageal varix (HP:0002040) | 2.14675234 |
| 80 | Emphysema (HP:0002097) | 2.14556275 |
| 81 | Diminished motivation (HP:0000745) | 2.14375743 |
| 82 | Long toe (HP:0010511) | 2.13889918 |
| 83 | Osteomyelitis (HP:0002754) | 2.13212682 |
| 84 | Joint stiffness (HP:0001387) | 2.12695459 |
| 85 | Thoracolumbar scoliosis (HP:0002944) | 2.11318202 |
| 86 | Recurrent skin infections (HP:0001581) | 2.11038561 |
| 87 | Hyperkalemia (HP:0002153) | 2.10270116 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.09588740 |
| 89 | Neonatal respiratory distress (HP:0002643) | 2.06978794 |
| 90 | Bowed forearm bones (HP:0003956) | 2.05951842 |
| 91 | Bowing of the arm (HP:0006488) | 2.05951842 |
| 92 | Shallow orbits (HP:0000586) | 2.05332114 |
| 93 | Abnormality of the pericardium (HP:0001697) | 2.03260124 |
| 94 | Metaphyseal irregularity (HP:0003025) | 2.03010212 |
| 95 | Retrobulbar optic neuritis (HP:0100654) | 2.01817104 |
| 96 | Optic neuritis (HP:0100653) | 2.01817104 |
| 97 | Prolonged neonatal jaundice (HP:0006579) | 2.01625281 |
| 98 | Flared iliac wings (HP:0002869) | 2.01355556 |
| 99 | Keratoconjunctivitis (HP:0001096) | 2.00994948 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.00420337 |
| 101 | Interstitial pulmonary disease (HP:0006530) | 11.3300328 |
| 102 | Conjunctival telangiectasia (HP:0000524) | 1.99381876 |
| 103 | Pulmonary hypertension (HP:0002092) | 1.97737264 |
| 104 | Dilatation of the ascending aorta (HP:0005111) | 1.97695644 |
| 105 | Basal ganglia calcification (HP:0002135) | 1.97435290 |
| 106 | J-shaped sella turcica (HP:0002680) | 1.95889000 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 1.95081692 |
| 108 | Hypergammaglobulinemia (HP:0010702) | 1.93217517 |
| 109 | Ankle contracture (HP:0006466) | 1.93127998 |
| 110 | Complement deficiency (HP:0004431) | 1.92716016 |
| 111 | Visceral angiomatosis (HP:0100761) | 1.92702118 |
| 112 | Myocardial infarction (HP:0001658) | 1.92328699 |
| 113 | Dysostosis multiplex (HP:0000943) | 1.92109345 |
| 114 | Follicular hyperkeratosis (HP:0007502) | 1.91914992 |
| 115 | Arterial tortuosity (HP:0005116) | 1.91298844 |
| 116 | Increased IgM level (HP:0003496) | 1.89847897 |
| 117 | Micronodular cirrhosis (HP:0001413) | 1.89724122 |
| 118 | Nasal polyposis (HP:0100582) | 1.89179596 |
| 119 | Wormian bones (HP:0002645) | 1.86860747 |
| 120 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.86593721 |
| 121 | Pulmonary infiltrates (HP:0002113) | 1.86432201 |
| 122 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83681165 |
| 123 | Obstructive lung disease (HP:0006536) | 1.83681165 |
| 124 | Restrictive lung disease (HP:0002091) | 1.82915661 |
| 125 | Hemangiomatosis (HP:0007461) | 1.82548489 |
| 126 | Petechiae (HP:0000967) | 1.81547148 |
| 127 | Plantar hyperkeratosis (HP:0007556) | 1.81135511 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.80400323 |
| 129 | Hydroxyprolinuria (HP:0003080) | 1.80400323 |
| 130 | Growth hormone excess (HP:0000845) | 1.80395586 |
| 131 | Recurrent fungal infections (HP:0002841) | 1.79693182 |
| 132 | Soft skin (HP:0000977) | 1.79383330 |
| 133 | Blue sclerae (HP:0000592) | 1.78827948 |
| 134 | Abnormality of complement system (HP:0005339) | 1.78803144 |
| 135 | Turricephaly (HP:0000262) | 1.78601607 |
| 136 | Thin bony cortex (HP:0002753) | 1.77954710 |
| 137 | Protuberant abdomen (HP:0001538) | 1.77821687 |
| 138 | Vasculitis (HP:0002633) | 1.76886562 |
| 139 | Milia (HP:0001056) | 1.76482104 |
| 140 | Abnormality of the lumbar spine (HP:0100712) | 1.75926918 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.75155083 |
| 142 | Premature rupture of membranes (HP:0001788) | 1.74579684 |
| 143 | Bronchitis (HP:0012387) | 1.74526116 |
| 144 | Bladder diverticulum (HP:0000015) | 1.73236552 |
| 145 | Inappropriate behavior (HP:0000719) | 1.72630152 |
| 146 | Aortic regurgitation (HP:0001659) | 1.72208541 |
| 147 | Albinism (HP:0001022) | 1.71927223 |
| 148 | Mucopolysacchariduria (HP:0008155) | 1.71796485 |
| 149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71796485 |
| 150 | Hemorrhage of the eye (HP:0011885) | 1.71389279 |
| 151 | Abnormality of purine metabolism (HP:0004352) | 1.70276523 |
| 152 | Cellulitis (HP:0100658) | 1.69531586 |
| 153 | Gastrointestinal infarctions (HP:0005244) | 1.69530209 |
| 154 | Abnormality of chloride homeostasis (HP:0011422) | 1.69197383 |
| 155 | Fragile nails (HP:0001808) | 1.68134903 |
| 156 | Bone pain (HP:0002653) | 1.67957036 |
| 157 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.67639911 |
| 158 | Hypertriglyceridemia (HP:0002155) | 1.66746918 |
| 159 | Xerostomia (HP:0000217) | 1.64862405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK7 | 3.31725939 |
| 2 | ERN1 | 3.14930876 |
| 3 | TRIB3 | 2.91733835 |
| 4 | ZAP70 | 2.81514114 |
| 5 | STK24 | 2.79358416 |
| 6 | FGFR2 | 2.64425306 |
| 7 | NME2 | 2.64111235 |
| 8 | RIPK1 | 2.61912541 |
| 9 | EPHB1 | 2.50841606 |
| 10 | LRRK2 | 2.35563692 |
| 11 | TAOK2 | 2.26566322 |
| 12 | CAMK1D | 2.25746222 |
| 13 | IRAK3 | 2.22859125 |
| 14 | ADRBK2 | 2.18925743 |
| 15 | TGFBR2 | 2.12171606 |
| 16 | TYK2 | 2.11111784 |
| 17 | MST1R | 2.05347944 |
| 18 | TBK1 | 1.94165976 |
| 19 | CDC42BPA | 1.92287611 |
| 20 | MAP3K14 | 1.91140977 |
| 21 | TIE1 | 1.89241652 |
| 22 | RIPK4 | 1.80854568 |
| 23 | IRAK4 | 1.79134512 |
| 24 | MST4 | 1.70240034 |
| 25 | MAP3K3 | 1.69695611 |
| 26 | BMPR2 | 1.63456447 |
| 27 | FGFR4 | 1.63122715 |
| 28 | BLK | 1.61377528 |
| 29 | PDGFRB | 1.58691053 |
| 30 | JAK1 | 1.57624368 |
| 31 | JAK3 | 1.53744829 |
| 32 | DAPK2 | 1.53469109 |
| 33 | PAK4 | 1.52506770 |
| 34 | MOS | 1.50918210 |
| 35 | FGFR3 | 1.49144815 |
| 36 | IKBKE | 1.48855928 |
| 37 | CAMK1G | 1.46485590 |
| 38 | CSK | 1.42904026 |
| 39 | EPHA3 | 1.41610894 |
| 40 | EPHB2 | 1.41430192 |
| 41 | TESK1 | 1.38786570 |
| 42 | TAOK3 | 1.34410278 |
| 43 | SIK1 | 1.33661191 |
| 44 | STK10 | 1.30723986 |
| 45 | ILK | 1.28909509 |
| 46 | PRPF4B | 1.26635664 |
| 47 | MAP3K11 | 1.26096725 |
| 48 | MAP2K3 | 1.25080270 |
| 49 | NEK9 | 1.22202580 |
| 50 | KIT | 1.20082750 |
| 51 | PBK | 1.19942696 |
| 52 | PIM2 | 1.18557791 |
| 53 | TAOK1 | 1.18043385 |
| 54 | CDK6 | 1.17432163 |
| 55 | EPHA2 | 1.16498669 |
| 56 | LMTK2 | 1.09779847 |
| 57 | MAP3K2 | 1.04338759 |
| 58 | MET | 1.02466943 |
| 59 | BMX | 1.00844142 |
| 60 | PTK6 | 1.00034949 |
| 61 | MAP4K1 | 0.98184937 |
| 62 | RPS6KA4 | 0.98164611 |
| 63 | PDGFRA | 0.95327236 |
| 64 | TXK | 0.95285895 |
| 65 | ACVR1B | 0.91945155 |
| 66 | LATS2 | 0.89460171 |
| 67 | CHUK | 0.88164537 |
| 68 | MATK | 0.87264454 |
| 69 | FRK | 0.83720752 |
| 70 | IKBKB | 0.81111178 |
| 71 | ARAF | 0.79445674 |
| 72 | FER | 0.78261752 |
| 73 | TTN | 0.77577437 |
| 74 | JAK2 | 0.77077032 |
| 75 | GSK3A | 0.76437591 |
| 76 | MAP3K5 | 0.76320905 |
| 77 | EGFR | 0.73287048 |
| 78 | LYN | 0.73106485 |
| 79 | ABL2 | 0.72202181 |
| 80 | IRAK2 | 0.68869519 |
| 81 | DDR2 | 0.67786651 |
| 82 | CSF1R | 0.67398526 |
| 83 | PAK2 | 0.66842326 |
| 84 | PRKD2 | 0.66456963 |
| 85 | MAP3K1 | 0.65988745 |
| 86 | TEC | 0.64994628 |
| 87 | ABL1 | 0.64763709 |
| 88 | STK3 | 0.64491331 |
| 89 | LATS1 | 0.63327671 |
| 90 | MAPK7 | 0.62548042 |
| 91 | IRAK1 | 0.59679320 |
| 92 | FGR | 0.59269278 |
| 93 | MAP3K9 | 0.58944879 |
| 94 | AKT3 | 0.58933723 |
| 95 | KSR2 | 0.58931487 |
| 96 | HIPK2 | 0.58928472 |
| 97 | LIMK1 | 0.58099632 |
| 98 | MYLK | 0.56308925 |
| 99 | HCK | 0.56061858 |
| 100 | CLK1 | 0.55130382 |
| 101 | MAP2K1 | 0.54656971 |
| 102 | PRKCD | 0.54238848 |
| 103 | PTK2B | 0.51887649 |
| 104 | PRKG2 | 0.51743238 |
| 105 | NTRK1 | 0.51212520 |
| 106 | MAPK4 | 0.49755429 |
| 107 | MAPK15 | 0.48379847 |
| 108 | PRKD1 | 0.48301156 |
| 109 | TRPM7 | 0.47744864 |
| 110 | PDPK1 | 0.46546618 |
| 111 | MARK3 | 0.45371169 |
| 112 | LCK | 0.45085540 |
| 113 | SYK | 0.44861466 |
| 114 | DAPK3 | 0.43960803 |
| 115 | TYRO3 | 0.43740652 |
| 116 | PTK2 | 0.42854811 |
| 117 | RPS6KA6 | 0.42652769 |
| 118 | PKN2 | 0.42309165 |
| 119 | PRKCQ | 0.42225459 |
| 120 | IGF1R | 0.41429384 |
| 121 | GRK5 | 0.40961090 |
| 122 | BTK | 0.39737688 |
| 123 | MAP2K2 | 0.39277665 |
| 124 | MAPKAPK2 | 0.39251259 |
| 125 | INSR | 0.37375705 |
| 126 | RPS6KL1 | 0.37264250 |
| 127 | RPS6KC1 | 0.37264250 |
| 128 | MELK | 0.34497716 |
| 129 | TGFBR1 | 0.34314176 |
| 130 | MAP3K13 | 0.34042139 |
| 131 | RPS6KA2 | 0.33927738 |
| 132 | PIK3CG | 0.31947864 |
| 133 | ADRBK1 | 0.30201791 |
| 134 | CAMKK2 | 0.26823944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64279493 |
| 2 | Malaria_Homo sapiens_hsa05144 | 2.57007616 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56687910 |
| 4 | Pertussis_Homo sapiens_hsa05133 | 2.52766641 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.47496418 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 2.15237272 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08474395 |
| 8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.00610104 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 1.94603389 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.93767350 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89565178 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77272863 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.76641997 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76380139 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75607489 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71892613 |
| 17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69534220 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68405030 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67488492 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.64811436 |
| 21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.62162630 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.61834293 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.60240538 |
| 24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.60126065 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54893599 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.54827508 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.47579900 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46176251 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44293519 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41670995 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30725791 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29365413 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.25014918 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.22180831 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19995260 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.18039338 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.17327172 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15458452 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15359995 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.15074445 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14609596 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11428951 |
| 43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10608762 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 1.06218200 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05085702 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04043678 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.00402056 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.00319134 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.99771566 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99274139 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96882386 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94378340 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90915736 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90322469 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90320551 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89806312 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88810363 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.88775119 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88487259 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87732283 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85429154 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82742486 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82350834 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.81882119 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.81872223 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.81571859 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79204431 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76859527 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74949520 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74874539 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72618760 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.71355680 |
| 73 | Hepatitis B_Homo sapiens_hsa05161 | 0.70852635 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69329783 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68532448 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66699550 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66417530 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65164316 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64841182 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64749347 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.63674371 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62955930 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58324804 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57701096 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53647500 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53509563 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53005394 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.52714496 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51975377 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51928687 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51854190 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50264259 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50113499 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48019390 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46609427 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46563444 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44770718 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44721337 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.44218121 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43864015 |
| 101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43584172 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42254995 |
| 103 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42205607 |
| 104 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41913900 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41463922 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40996737 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39423355 |
| 108 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39406075 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37046198 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37035605 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36524630 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35954989 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35824926 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34425074 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30428345 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24580218 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22820059 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22135970 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20580552 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19836277 |
| 121 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.19304629 |

